Search Within

Neeta Pandit-Taskar

  1. "Susan Slovin"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Department of Medicine (11)
  2. GSK Faculty (11)
  3. Genitourinary Oncology Service (11)
  4. Hematologic Malignancies, Division of (11)
  5. Molecular Imaging and Therapy Service (11)
  6. Molecular Pharmacology and Chemistry Program Faculty (11)

More Groups

People
  1. Howard Scher (11)
  2. Michael Morris (11)
  3. Steven Larson (11)
  4. Susan Slovin (11)
  5. Dana Rathkopf (8)
  6. Jorge Carrasquillo (8)

More People

Years
  1. 2016 (1)
  2. 2015 (2)
  3. 2013 (2)
  4. 2009 (2)
  5. 2008 (1)
  6. 2007 (2)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Clinical Cancer Research (2)
  3. Cancer (1)
  4. European Journal of Nuclear Medicine and Molecular Imaging (1)
Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (2)
  3. Springer (1)
  4. Wiley Blackwell (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Repetitively dosed docetaxel and 153samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
    Journal Article

    Autio, K. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Stephenson, R. D.; Slovin, S. F.; Rathkopf, D. E.; Hong, C.; Heller, G.; Scher, H. I.; Larson, S. M.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Phase i pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
    Journal Article

    Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Humm, J. L.; Rathkopf, D. E.; Slovin, S. F.; Williamson, M. J.; Lacuna, K.; Aksnes, A. K.; Larson, S. M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J.; Divgi, C. R.; Slovin, S.; Kelly, W. K.; Rathkopf, D.; Gignac, G. A.; Solit, D.; Schwartz, L.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of docetaxel (Tax) and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Solit, D.; Rathkopf, D. E.; Carrasquillo, J. A.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save